KME-2780 | m-entrepreneurship.com

Product Name :
KME-2780

Search keywords :
KME-2780

drugId :
null

Target Vo:
Interleukin-1 receptor-associated kinase 1

Target Vo Short Name :
IRAK1

Moa_Name:
Interleukin-1 receptor-associated kinase 1 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Cincinnati Children’S Hospital Medical Center

Active Company_Name :
Kurome Therapeutics Inc

Active Indication_Name:
Myelodysplastic Syndromes

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Collagen I alpha 2 Antibody
Wnt5b Antibody (YA653)
HDAC2 Antibody: HDAC2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 55 kDa, targeting to HDAC2. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse, Rat.

Author: Betaine hydrochloride

Related Posts